Drug|Drug Interactions Potential of Direct|Acting Antivirals for the ...

Drug-Drug Interactions Potential of Direct-Acting Antivirals for the ...

The advent of direct-acting antiviral agents (DAAs) has transformed the hepatitis C virus (HCV) therapeutic landscape in terms of efficacy and safety, ...

Drug-drug interactions between direct-acting antivirals and co ...

Background: The increasing number of direct-acting antiviral (DAA) regimens along with limited number of subjects and co-medications involved in ...

Prevalence of Potential Drug Interactions With Direct-Acting ...

COVID-19 direct-acting antivirals could have potential drug-drug interactions (DDI). •. Higher prevalence of potential DDIs in older patients ...

Drug-Drug Interactions Potential of Direct Acting Antivirals for the ...

However, an important potential for drug-drug interactions (DDIs) is expected with these combinations, particularly in patients with other comorbidities (e.g. ...

Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral

The newly approved DAA regimens may be prescribed with other drugs simultaneously, increasing the potential of pharmacokinetic interactions.

Prevalence of Potential Drug Interactions With Direct-Acting ...

Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for. COVID-19 Among Hospitalized Patients. Essy Mozaffari, PharmD, MPH, MBA1, Aastha ...

Potential for Drug-Drug Interactions between Antiretrovirals ... - PLOS

Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral ...

Review of Clinically Relevant Drug Interactions with Next ...

In this review, we examine the pharmacokinetics and clinically relevant drug interactions of the newer generation direct-acting antivirals ...

Drug–Drug Interactions Between Direct-Acting Antivirals and ...

Various antipsychotics, SSRIs, and TCAs have the potential to inhibit CYP2D6, which makes these drugs perpetrators of drug interactions. However ...

Comedications and potential drug-drug interactions with direct ...

Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis.

Drug–drug interactions with direct‐acting antivirals - Semantic Scholar

Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors ...

Drug-drug interactions between direct-acting antivirals and

As the first line of treatment for hepatitis C virus (HCV) infection, direct-acting antivirals (DAAs) have greater efficacy and fewer adverse effects than other ...

Direct-Acting Antivirals (DAAs): Drug-Drug Interactions (DDIs) in the ...

Direct antiviral agents (DAAs) improved tolerability and efficacy for HCV-infected patients, but drug-drug interactions (DDIs) have the ...

Effectiveness and potential drug interactions in antiviral therapy for ...

Direct-acting antivirals used in the treatment of hepatitis C have demonstrated high rates of efficacy, are well tolerated and considered safe.

Prevalence of the potential drug–drug interactions between ...

To determine the comorbidity and potential for drug–drug interactions (DDIs) among pangenotypic direct-acting-antivirals (pDAAs) and the concomitant ...

Drug–drug interactions between direct-acting antivirals and co ...

... Drug-drug interactions between a DAA and other concomitant medications (such as PPIs, statins and antipsychotics) remain a concern prior to HCV therapy. 28 ...

DOI - Clinical and Molecular Hepatology

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis. Po-Yao Hsu1,2, Yu ...

Management of drug interactions with direct‐acting antivirals in ...

Direct-acting antivirals (DAAs) for treatment of chronic hepatitis C virus (HCV) infection can cause drug–drug interactions (DDIs) with ...

Comedications and potential drug-drug interactions with direct ...

Background/Aims: Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on ...

Drug-Drug Interactions Between Direct-Acting Antivirals and ...

... possible victims or perpetrators of drug-drug interactions (DDIs). There is a high prevalence of mental illnesses such as depression or psychosis in HCV ...